tezepelumab

tezepelumab Tezepelumab Granted Priority Review By U.S. FDA THOUSAND OAKS, Calif., July 7, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and […]